These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 26027626)

  • 1. Effectiveness of implantable cardioverter-defibrillators in survivors of inhospital cardiac arrest.
    Chan PS; Krumholz HM; Spertus JA; Curtis LH; Li Y; Hammill BG; Nallamothu BK;
    Am Heart J; 2015 Jun; 169(6):870-878.e1. PubMed ID: 26027626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: a prospective follow-up study.
    Parkash R; Tang A; Wells G; Blackburn J; Stiell I; Simpson C; Dorian P; Yee R; Cameron D; Connolly S; Birnie D; Nichol G
    CMAJ; 2004 Oct; 171(9):1053-6. PubMed ID: 15505267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival after successful inhospital cardiac arrest resuscitation.
    Bloom HL; Shukrullah I; Cuellar JR; Lloyd MS; Dudley SC; Zafari AM
    Am Heart J; 2007 May; 153(5):831-6. PubMed ID: 17452161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators.
    Herzog CA; Li S; Weinhandl ED; Strief JW; Collins AJ; Gilbertson DT
    Kidney Int; 2005 Aug; 68(2):818-25. PubMed ID: 16014061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure.
    Chen CY; Stevenson LW; Stewart GC; Bhatt DL; Desai M; Seeger JD; Williams L; Jalbert JJ; Setoguchi S
    BMJ; 2015 Jul; 351():h3529. PubMed ID: 26174233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in treated ventricular fibrillation out-of-hospital cardiac arrest: a 17-year population-based study.
    Bunch TJ; White RD; Friedman PA; Kottke TE; Wu LA; Packer DL
    Heart Rhythm; 2004 Sep; 1(3):255-9. PubMed ID: 15851165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of body weight with total mortality and with ICD shocks among survivors of ventricular fibrillation in out-of-hospital cardiac arrest.
    Bunch TJ; White RD; Lopez-Jimenez F; Thomas RJ
    Resuscitation; 2008 Jun; 77(3):351-5. PubMed ID: 18308453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of sudden cardiac arrest survivors and electrophysiologically guided antiarrhythmic therapy.
    Hennersdorf MG; Niebch V; Vester EG; Winter J; Perings C; Strauer BE
    Cardiology; 2003; 99(4):190-7. PubMed ID: 12845245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death.
    Curtis LH; Al-Khatib SM; Shea AM; Hammill BG; Hernandez AF; Schulman KA
    JAMA; 2007 Oct; 298(13):1517-24. PubMed ID: 17911496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Neurological Status on Defibrillator Therapy and Long-Term Mortality of Sudden Cardiac Arrest Survivors.
    Barakat AF; Thalappillil A; Qin D; Ladejobi A; Bhonsale A; Kancharla K; Wang NC; Adelstein E; Jain S; Estes NAM; Saba S
    JACC Clin Electrophysiol; 2019 Jul; 5(7):843-850. PubMed ID: 31320013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients.
    Pokorney SD; Hellkamp AS; Yancy CW; Curtis LH; Hammill SC; Peterson ED; Masoudi FA; Bhatt DL; Al-Khalidi HR; Heidenreich PA; Anstrom KJ; Fonarow GC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):145-51. PubMed ID: 25504649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome.
    Madhavan M; Friedman PA; Lennon RJ; Prasad A; White RD; Sriram CS; Gulati R; Gersh BJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to programmed ventricular stimulation and clinical outcome in cardiac arrest survivors receiving randomised assignment to implantable cardioverter defibrillator or antiarrhythmic drug therapy.
    Cappato R; Boczor S; Kuck KH;
    Eur Heart J; 2004 Apr; 25(8):642-9. PubMed ID: 15084368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the decision to ICD implantation in survivors of OHCA and its influence on long term survival.
    Martinell L; Herlitz J; Lindqvist J; Gottfridsson C
    Resuscitation; 2013 Feb; 84(2):213-7. PubMed ID: 22922177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit.
    Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Initial Recorded Rhythm on Cardioverter-Defibrillator Insertion and Subsequent All-Cause Mortality in Sudden Cardiac Arrest Survivors.
    Polsinelli VB; Wang NC; Kancharla K; Bhonsale A; Jain SK; Saba S
    Am J Cardiol; 2019 Sep; 124(5):709-714. PubMed ID: 31279406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death without inducible arrhythmias.
    Crandall BG; Morris CD; Cutler JE; Kudenchuk PJ; Peterson JL; Liem LB; Broudy DR; Greene HL; Halperin BD; McAnulty JH
    J Am Coll Cardiol; 1993 Apr; 21(5):1186-92. PubMed ID: 8459075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.